Patents by Inventor Michael SKOV

Michael SKOV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-Abeta Antibodies
    Publication number: 20230331828
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Application
    Filed: September 12, 2022
    Publication date: October 19, 2023
    Inventors: Michael SKOV, Tarlochan S. NIJJAR, Frédérique BARD, Robin BARBOUR, Wagner ZAGO
  • Anti-abeta antibodies
    Patent number: 11440953
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Grant
    Filed: April 20, 2022
    Date of Patent: September 13, 2022
    Assignee: OTHAIR PROTHENA LIMITED
    Inventors: Michael Skov, Tarlochan S. Nijjar, Frédérique Bard, Robin Barbour, Wagner Zago
  • Anti-Abeta antibodies
    Patent number: 11434284
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: September 6, 2022
    Assignee: OTHAIR PROTHENA LIMITED
    Inventors: Michael Skov, Tarlochan S. Nijjar, Frédérique Bard, Robin Barbour, Wagner Zago
  • Anti-Abeta antibodies
    Patent number: 11434285
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: September 6, 2022
    Assignee: OTHAIR PROTHENA LIMITED
    Inventors: Michael Skov, Tarlochan S. Nijjar, Frédérique Bard, Robin Barbour, Wagner Zago
  • Anti-abeta antibodies
    Patent number: 11434283
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: September 6, 2022
    Assignee: OTHAIR PROTHENA LIMITED
    Inventors: Michael Skov, Tarlochan S. Nijjar, Frédérique Bard, Robin Barbour, Wagner Zago
  • Anti-Abeta Antibodies
    Publication number: 20220242940
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Application
    Filed: April 20, 2022
    Publication date: August 4, 2022
    Inventors: Michael SKOV, Tarlochan S. NIJJAR, Frédérique BARD, Robin BARBOUR, Wagner ZAGO
  • Anti-Abeta Antibodies
    Publication number: 20220089762
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Application
    Filed: October 25, 2021
    Publication date: March 24, 2022
    Inventors: Michael SKOV, Tarlochan S. NIJJAR, Sridhar GOVINDARAJAN, Tom PURCELL, Mark WELCH, Frédérique BARD, Robin BARBOUR, Wagner ZAGO
  • Anti-Abeta Antibodies
    Publication number: 20220049009
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Application
    Filed: July 23, 2021
    Publication date: February 17, 2022
    Inventors: Michael SKOV, Tarlochan S. NIJJAR, Sridhar GOVINDARAJAN, Tom PURCELL, Mark WELCH, Frédérique BARD, Robin BARBOUR, Wagner ZAGO
  • Anti-Abeta Antibodies
    Publication number: 20220041700
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Application
    Filed: October 25, 2021
    Publication date: February 10, 2022
    Inventors: Michael SKOV, Tarlochan S. NIJJAR, Sridhar GOVINDARAJAN, Tom PURCELL, Mark WELCH, Frédérique BARD, Robin BARBOUR, Wagner ZAGO
  • Anti-Abeta Antibodies
    Publication number: 20220041701
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Application
    Filed: October 25, 2021
    Publication date: February 10, 2022
    Inventors: Michael SKOV, Tarlochan S. NIJJAR, Sridhar GOVINDARAJAN, Tom PURCELL, Mark WELCH, Frédérique BARD, Robin BARBOUR, Wagner ZAGO
  • Anti-Abeta Antibodies
    Publication number: 20220041699
    Abstract: Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
    Type: Application
    Filed: October 25, 2021
    Publication date: February 10, 2022
    Inventors: Michael SKOV, Tarlochan S. NIJJAR, Sridhar GOVINDARAJAN, Tom PURCELL, Mark WELCH, Frédérique BARD, Robin BARBOUR, Wagner ZAGO